Growth Metrics

Marchex (MCHX) EBIAT (2016 - 2025)

Marchex (MCHX) has 16 years of EBIAT data on record, last reported at -$2.3 million in Q4 2025.

  • On a quarterly basis, EBIAT fell 21.31% to -$2.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$5.2 million, a 5.82% decrease, with the full-year FY2025 number at -$5.2 million, down 5.82% from a year prior.
  • EBIAT reached -$2.3 million in Q4 2025 per MCHX's latest filing, down from -$1.0 million in the prior quarter.
  • Over the last five years, EBIAT for MCHX hit a ceiling of $3.3 million in Q3 2021 and a floor of -$5.3 million in Q1 2021.
  • A 5-year average of -$1.6 million and a median of -$1.6 million in 2022 define the central range for EBIAT.
  • Peak YoY movement for EBIAT: surged 164.35% in 2021, then plummeted 359.76% in 2022.
  • Tracing MCHX's EBIAT over 5 years: stood at -$2.0 million in 2021, then plummeted by 75.63% to -$3.6 million in 2022, then surged by 68.02% to -$1.1 million in 2023, then tumbled by 67.1% to -$1.9 million in 2024, then decreased by 21.31% to -$2.3 million in 2025.
  • Business Quant data shows EBIAT for MCHX at -$2.3 million in Q4 2025, -$1.0 million in Q3 2025, and $84000.0 in Q2 2025.